Cynthia L. Palmer
Pfizer (United States)(US)Université Bourgogne Franche-Comté(FR)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cell Adhesion Molecules Research, NF-κB Signaling Pathways, Latin American Literature Studies, Computational Drug Discovery Methods
Most-Cited Works
- → Discovery of (10 R )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- 2H -8,4-(metheno)pyrazolo[4,3- h ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations(2014)574 cited
- → Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib(2014)117 cited
- → Growth kinetics and chemoprevention of aberrant crypts in the rat colon(1992)68 cited
- → CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety(2025)39 cited
- Moksha: Aldous Huxley's Classic Writings on Psychedelics and the Visionary Experience(1977)
- → Predictors for chemotherapy-related severe or febrile neutropenia: a review of the clinical literature(2001)37 cited
- → Cost-Effectiveness Analysis of Entacapone in Parkinson's Disease: A Markov Process Analysis(2001)37 cited
- MOKSHA - Writings on Psychedelics and the Visionary Experience 1931 - 1963(1983)
- → Best Practice Implementation: Lessons Learned from 20 Partnerships(2007)21 cited
- Sisters of the extreme : women writing on the drug experience(2000)